Application Note

Manufacturing of hiPSC-Derived Cardiomyocytes

Format: PDF file | Document type: Application Note | Promoted Content

This content is provided by Eppendorf Bioprocess Solutions, and any views and opinions expressed do not necessarily reflect those of

Manufacturing of hiPSC-Derived Cardiomyocytes

Effective drug discovery and development relies on the availability of predictive preclinical model systems. Technologies based on human induced pluripotent stem cells (hiPSC) hold great promise to overcome this challenge.

In this application note researchers from Ncardia® show how they developed a bioprocess for the large-scale manufacturing of cardiomyocytes derived from a variety of healthy and diseased hiPSC lines for implementation into their DiscoverHIT platform.

Related resources from Eppendorf Bioprocess Solutions

Show more

Supplier info centre